HBK Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

HBK Investments’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,000,000	Closed	-$78.7M	–	470
2023 Q2	$78.7M	Buy	+2,000,000	New	+$70.6M	0.42%	16
2016 Q4	–	Sell	-11,700	Closed	-$540K	–	922
2016 Q3	$540K	Buy	+11,700	New	+$660K	﹤0.01%	624
2016 Q2	–	Sell	-17,197	Closed	-$727K	–	1117
2016 Q1	$727K	Buy	+17,197	New	+$876K	0.01%	664
2015 Q3	–	Sell	-13,999	Closed	-$729K	–	1159
2015 Q2	$729K	Buy	13,999 +6,999	+100%	+$348K	0.01%	639
2015 Q1	$326K	Buy	+7,000	New	+$363K	﹤0.01%	844

HBK Investments's ISEE Position: Q3 2023 in Review

HBK Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 2,000,000 shares — an estimated $78.7M sold.

HBK Investments first reported a position in ISEE in Q1 2015 and held it in 5 quarters. The position peaked at $78.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

HBK Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
HBK Investments sold 2,000,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $78.7M.
HBK Investments first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
HBK Investments's IVERIC bio, Inc. Common Stock position peaked at $78.7M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.